These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 22655082)

  • 1. Host immune responses to a viral immune modulating protein: immunogenicity of viral interleukin-10 in rhesus cytomegalovirus-infected rhesus macaques.
    Eberhardt MK; Chang WL; Logsdon NJ; Yue Y; Walter MR; Barry PA
    PLoS One; 2012; 7(5):e37931. PubMed ID: 22655082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and analysis of rhesus cytomegalovirus IL-10 mutants as a model for novel vaccines against human cytomegalovirus.
    Logsdon NJ; Eberhardt MK; Allen CE; Barry PA; Walter MR
    PLoS One; 2011; 6(11):e28127. PubMed ID: 22132227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccination against a virus-encoded cytokine significantly restricts viral challenge.
    Eberhardt MK; Deshpande A; Chang WL; Barthold SW; Walter MR; Barry PA
    J Virol; 2013 Nov; 87(21):11323-31. PubMed ID: 23946461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploitation of Interleukin-10 (IL-10) Signaling Pathways: Alternate Roles of Viral and Cellular IL-10 in Rhesus Cytomegalovirus Infection.
    Eberhardt MK; Deshpande A; Fike J; Short R; Schmidt KA; Blozis SA; Walter MR; Barry PA
    J Virol; 2016 Nov; 90(21):9920-9930. PubMed ID: 27558431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attenuation of innate immunity by cytomegalovirus IL-10 establishes a long-term deficit of adaptive antiviral immunity.
    Chang WL; Barry PA
    Proc Natl Acad Sci U S A; 2010 Dec; 107(52):22647-52. PubMed ID: 21149711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neutralization of rhesus cytomegalovirus IL-10 reduces horizontal transmission and alters long-term immunity.
    Deere JD; Chang WLW; Villalobos A; Schmidt KA; Deshpande A; Castillo LD; Fike J; Walter MR; Barry PA; Hartigan-O'Connor DJ
    Proc Natl Acad Sci U S A; 2019 Jun; 116(26):13036-13041. PubMed ID: 31189602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and Functional Characterization of a Novel Fc Gamma-Binding Glycoprotein in Rhesus Cytomegalovirus.
    Kolb P; Sijmons S; McArdle MR; Taher H; Womack J; Hughes C; Ventura A; Jarvis MA; Stahl-Hennig C; Hansen S; Picker LJ; Malouli D; Hengel H; Früh K
    J Virol; 2019 Feb; 93(4):. PubMed ID: 30487278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathogenesis of Wild-Type-Like Rhesus Cytomegalovirus Strains following Oral Exposure of Immune-Competent Rhesus Macaques.
    Yue Y; Chang WLW; Li J; Nguyen N; Schmidt KA; Dormitzer PR; Yang X; Barry PA
    J Virol; 2022 Feb; 96(3):e0165321. PubMed ID: 34788083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogenicity and protective efficacy of DNA vaccines expressing rhesus cytomegalovirus glycoprotein B, phosphoprotein 65-2, and viral interleukin-10 in rhesus macaques.
    Yue Y; Kaur A; Eberhardt MK; Kassis N; Zhou SS; Tarantal AF; Barry PA
    J Virol; 2007 Feb; 81(3):1095-109. PubMed ID: 17108040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody responses to rhesus cytomegalovirus glycoprotein B in naturally infected rhesus macaques.
    Yue Y; Zhou SS; Barry PA
    J Gen Virol; 2003 Dec; 84(Pt 12):3371-3379. PubMed ID: 14645918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural history of postnatal rhesus cytomegalovirus shedding by dams and acquisition by infant rhesus monkeys.
    Kaur A; Itell HL; Ehlinger EP; Varner V; Gantt S; Permar SR
    PLoS One; 2018; 13(10):e0206330. PubMed ID: 30356332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of vaccination with rhesus CMV (RhCMV) soluble gB with a RhCMV replication-defective virus deleted for MHC class I immune evasion genes in a RhCMV challenge model.
    Valencia S; Gill RB; Dowdell KC; Wang Y; Hornung R; Bowman JJ; Lacayo JC; Cohen JI
    Vaccine; 2019 Jan; 37(2):333-342. PubMed ID: 30522906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutralization of Diverse Human Cytomegalovirus Strains Conferred by Antibodies Targeting Viral gH/gL/pUL128-131 Pentameric Complex.
    Ha S; Li F; Troutman MC; Freed DC; Tang A; Loughney JW; Wang D; Wang IM; Vlasak J; Nickle DC; Rustandi RR; Hamm M; DePhillips PA; Zhang N; McLellan JS; Zhu H; Adler SP; McVoy MA; An Z; Fu TM
    J Virol; 2017 Apr; 91(7):. PubMed ID: 28077654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization and immunological analysis of the rhesus cytomegalovirus homologue (Rh112) of the human cytomegalovirus UL83 lower matrix phosphoprotein (pp65).
    Yue Y; Kaur A; Zhou SS; Barry PA
    J Gen Virol; 2006 Apr; 87(Pt 4):777-787. PubMed ID: 16528025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Limited dissemination and shedding of the UL128 complex-intact, UL/b'-defective rhesus cytomegalovirus strain 180.92.
    Assaf BT; Mansfield KG; Strelow L; Westmoreland SV; Barry PA; Kaur A
    J Virol; 2014 Aug; 88(16):9310-20. PubMed ID: 24899204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experimental coinfection of rhesus macaques with rhesus cytomegalovirus and simian immunodeficiency virus: pathogenesis.
    Sequar G; Britt WJ; Lakeman FD; Lockridge KM; Tarara RP; Canfield DR; Zhou SS; Gardner MB; Barry PA
    J Virol; 2002 Aug; 76(15):7661-71. PubMed ID: 12097580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human Cytomegalovirus UL111A and US27 Gene Products Enhance the CXCL12/CXCR4 Signaling Axis via Distinct Mechanisms.
    Tu CC; Arnolds KL; O'Connor CM; Spencer JV
    J Virol; 2018 Mar; 92(5):. PubMed ID: 29237840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Horizontal Transmission of Cytomegalovirus in a Rhesus Model Despite High-Level, Vaccine-Elicited Neutralizing Antibody and T-Cell Responses.
    Li J; Wellnitz S; Chi XS; Yue Y; Schmidt KA; Nguyen N; Chen W; Yurgelonis I; Rojas E; Liu Y; Loschko J; Pollozi E; Matsuka YV; Needle E; Vidunas E; Donald RGK; Moran J; Jansen KU; Dormitzer PR; Barry PA; Yang X
    J Infect Dis; 2022 Sep; 226(4):585-594. PubMed ID: 35413121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibodies to human IL-10 neutralize ebvIL-10-mediated cytokine suppression but have no effect on cmvIL-10 activity.
    Brodeur ND; Spencer JV
    Virus Res; 2010 Nov; 153(2):265-8. PubMed ID: 20728483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathogenesis of experimental rhesus cytomegalovirus infection.
    Lockridge KM; Sequar G; Zhou SS; Yue Y; Mandell CP; Barry PA
    J Virol; 1999 Nov; 73(11):9576-83. PubMed ID: 10516066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.